This is an archive of papers published by the staff and faculty of Fox Chase Cancer Center. For questions about content, please contact Talbot Research Library
Last updated on
Galloway TJ , Lango MN , Burtness B , Mehra R , Ruth K , Ridge JA
Unilateral neck therapy in the human papillomavirus ERA: accepted regional spread patterns
Head Neck. 2013 Feb;35(2) :160-4
PMID: 22302641 PMCID: PMC 4037756
AbstractBACKGROUND: The purpose of this study was to determine whether the incidence of bilateral neck disease tonsillar cancer is rising. METHODS: We reviewed tonsillar cancer incidence data from the Surveillance, Epidemiology, and End Results (SEER) Program of the National Cancer Institute. RESULTS: The annual incidence of advanced neck disease (>/=N2) with small primary tonsillar cancer is increasing (annual percent change [APC]; p < .05) during 2 evaluable time frames (1988-2003 and 2004-2008). The increase for small primary tonsillar cancer from 2004 to 2008 is associated with increased ipsilateral disease (ie, T1-2N2a-b, APC 10.6%; p < .05) rather than bilateral neck disease (T1-2N2c, APC 5.9%, APC = NS). The increase in bilateral neck disease is less than the overall rise in T1 to 2 tonsillar cancer (APC 7.2%; p < .05). CONCLUSION: In the human papillomavirus (HPV) era, bilateral neck disease is increasingly common. This seems to be a consequence of the increasing incidence of tonsillar cancer rather than a new biologic behavior.
NotesGalloway, Thomas J Lango, Miriam N Burtness, Barbara Mehra, Ranee Ruth, Karen Ridge, John A United States Head & neck Head Neck. 2013 Feb;35(2):160-4. doi: 10.1002/hed.22929. Epub 2012 Feb 2.